[Pharmacology of S-1702. Its action on glycemia and the microvascular system of normal and diabetic animals].
D000818:Animals; D001485:Basement Membrane / Q000187:drug effects; D001786:Blood Glucose / Q000378:metabolism*; D002196:Capillaries / Q000187:drug effects*; D003921:Diabetes Mellitus, Experimental / Q000188:drug therapy; D003925:Diabetic Angiopathies / Q000188:drug therapy; D004342:Drug Hypersensitivity; D004727:Endothelium / Q000187:drug effects; D008833:Microcirculation / Q000187:drug effects; D051381:Rats; D013453:Sulfonylurea Compounds / Q000494:pharmacology* / Q000627:therapeutic use; D013927:Thrombosis / Q000517:prevention & control
D001786:Blood Glucose; D013453:Sulfonylurea Compounds
Pharmacologie du S-1702. Action sur la glycémie et le système microvasculaire d'animaux normaux et diabétiques